Ryoji Matsumoto

Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production.

Eiichiro Sonoda, Ryoji Matsumoto, Y Hitoshi et al. · The Journal of Experimental Medicine · 1989 · 398 citations · Full text

Human Growth, T-regulatory Cell, Immunology +18

Human Ecalectin, a Variant of Human Galectin-9, Is a Novel Eosinophil Chemoattractant Produced by T Lymphocytes

Ryoji Matsumoto, Hiroyuki Matsumoto, Masako Seki et al. · Journal of Biological Chemistry · 1998 · 301 citations · Full text

Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production.

A Tominaga, N. Koyama, Shigeki Katoh et al. · The Journal of Experimental Medicine · 1991 · 297 citations · Full text

Lymphocyte Development, Immunology, Immune Regulation +18

Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype.

Daniel S. Friend, N. P. Ghildyal, K. Frank Austen et al. · The Journal of Cell Biology · 1996 · 228 citations · Full text

Granule Protease Phenotype, Laboratory Immunology, Mast Cell Disorder +18

Prostaglandin endoperoxide synthase-1 and -2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells.

Makoto Murakami, Ryoji Matsumoto, K. Frank Austen et al. · Journal of Biological Chemistry · 1994 · 217 citations · Full text

Sclerostin, Arachidonic Acid Metabolism, Mast Cell Disorder +24